Gregory R Mullen1, Steven A Kaplan2. 1. Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, 10029, USA. 2. Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, 10029, USA. steven.kaplan@mountsinai.org.
Abstract
PURPOSE OF REVIEW: To review the efficacy and safety of mirabegron in men with overactive bladder (OAB) and benign prostatic hyperplasia (BPH). RECENT FINDINGS: Numerous studies have shown mirabegron to be efficacious and safe in treating symptoms of OAB. More recent studies evaluating the use of mirabegron in men with OAB and BPH have also shown the medication to be effective with few adverse side effects when used as monotherapy or in combination therapy. Mirabegron is an effective and safe treatment for men with OAB and BPH.
PURPOSE OF REVIEW: To review the efficacy and safety of mirabegron in men with overactive bladder (OAB) and benign prostatic hyperplasia (BPH). RECENT FINDINGS: Numerous studies have shown mirabegron to be efficacious and safe in treating symptoms of OAB. More recent studies evaluating the use of mirabegron in men with OAB and BPH have also shown the medication to be effective with few adverse side effects when used as monotherapy or in combination therapy. Mirabegron is an effective and safe treatment for men with OAB and BPH.
Authors: Carlos D'Ancona; Bernard Haylen; Matthias Oelke; Luis Abranches-Monteiro; Edwin Arnold; Howard Goldman; Rizwan Hamid; Yukio Homma; Tom Marcelissen; Kevin Rademakers; Alexis Schizas; Ajay Singla; Irela Soto; Vincent Tse; Stefan de Wachter; Sender Herschorn Journal: Neurourol Urodyn Date: 2019-01-25 Impact factor: 2.696
Authors: E C Alexandre; L R Kiguti; F B Calmasini; F H Silva; K P da Silva; R Ferreira; C A Ribeiro; F Z Mónica; A S Pupo; E Antunes Journal: Br J Pharmacol Date: 2016-01-15 Impact factor: 8.739
Authors: Arnav Agarwal; Leyla N Eryuzlu; Rufus Cartwright; Kristian Thorlund; Teuvo L J Tammela; Gordon H Guyatt; Anssi Auvinen; Kari A O Tikkinen Journal: Eur Urol Date: 2014-01-24 Impact factor: 20.096